Novartis AG (NVS)
97.11
+0.34
(+0.35%)
USD |
NYSE |
Dec 20, 16:00
97.08
-0.02
(-0.03%)
Pre-Market: 20:00
Novartis Debt to Equity Ratio: 0.6999 for Sept. 30, 2024
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Eli Lilly and Co | 2.185 |
| Pfizer Inc | 0.7219 |
| PTC Therapeutics Inc | -0.2704 |
| Monte Rosa Therapeutics Inc | 0.00 |
| AstraZeneca PLC | 0.7402 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 103.52B |
| Total Liabilities (Quarterly) | 60.08B |
| Shareholders Equity (Quarterly) | 43.32B |
| Current Ratio | 1.111 |
| Net Debt Paydown Yield | -0.33% |